[1]
‘Review of immune-metabolic studies and re-purposed treatments of Nigerian COVID-19 patients: A pointer to mild, gender- and age-based status of admitted patients’, NJPS, vol. 39, nr. 2, pp. 177–183, dec. 2024, doi: 10.54548/njps.v39i2.2.